The impairmentof the EZH2–EED interaction led to proliferation arrest andmyeloid differentiation in PRC2-dependent MLL-AF9 leukemia cells andremarkably affected the viability of cancer cells bearing EZH2 mutantvariants. The gene discussed is EZH2; the disease is cancer.